[go: up one dir, main page]

BRPI0510319A - inibidores da enzima integrase de hiv - Google Patents

inibidores da enzima integrase de hiv

Info

Publication number
BRPI0510319A
BRPI0510319A BRPI0510319-3A BRPI0510319A BRPI0510319A BR PI0510319 A BRPI0510319 A BR PI0510319A BR PI0510319 A BRPI0510319 A BR PI0510319A BR PI0510319 A BRPI0510319 A BR PI0510319A
Authority
BR
Brazil
Prior art keywords
integrase enzyme
enzyme inhibitors
hiv integrase
hiv
inhibitors
Prior art date
Application number
BRPI0510319-3A
Other languages
English (en)
Inventor
Klaus Ruprecht Dress
Qiyue Hu
Ted William Johnson
Michael Bruno Plewe
Steven Paul Tanis
Hai Wang
Anle Yang
Chunfeng Yin
Junhu Zhang
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BRPI0510319A publication Critical patent/BRPI0510319A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

INIBIDORES DA ENZIMA INTEGRASE DE HIV. A presente invenção refere-se a compostos de fórmula (I), e sais e solvatos farmaceuticamente aceitáveis dos mesmos, sua síntese e seu uso como moduladores ou inibidores da enzima integrase do vírus da imunodeficiência humana ("HIV").
BRPI0510319-3A 2004-04-26 2005-04-14 inibidores da enzima integrase de hiv BRPI0510319A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56570504P 2004-04-26 2004-04-26
US66050205P 2005-03-09 2005-03-09
PCT/IB2005/001029 WO2005103003A2 (en) 2004-04-26 2005-04-14 Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors

Publications (1)

Publication Number Publication Date
BRPI0510319A true BRPI0510319A (pt) 2007-10-16

Family

ID=35033770

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510319-3A BRPI0510319A (pt) 2004-04-26 2005-04-14 inibidores da enzima integrase de hiv

Country Status (7)

Country Link
US (1) US7468375B2 (pt)
EP (1) EP1756103A2 (pt)
JP (1) JP2007534739A (pt)
BR (1) BRPI0510319A (pt)
CA (1) CA2564356A1 (pt)
MX (1) MXPA06012449A (pt)
WO (1) WO2005103003A2 (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8586801A1 (es) 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
WO2005103003A2 (en) 2004-04-26 2005-11-03 Pfizer Inc. Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
BRPI0510306A (pt) 2004-04-26 2007-09-04 Pfizer inibidores da enzima de hiv integrase,composição farmacêutica contendo os referidos inibidores bem como seu uso
CA2578841A1 (en) * 2004-09-07 2006-03-16 Pfizer Inc. Inhibitors of the hiv integrase enzyme
WO2007039802A1 (en) * 2005-10-03 2007-04-12 Pfizer Products Inc. Inhibitors of the hiv integrase enzyme
WO2008095276A1 (en) * 2007-02-06 2008-08-14 Cymcorp International, Inc. Novel non-toxic composition and method of using such for treating a degenerative or an immune system-related disease
WO2009146555A1 (en) 2008-06-04 2009-12-10 Ambrilia Biopharma Inc. Hiv integrase inhibitors from pyridoxine
US8568659B2 (en) * 2008-09-11 2013-10-29 Mabgen, Llc Fiber optic device
US8993808B2 (en) 2009-01-21 2015-03-31 Oryzon Genomics, S.A. Phenylcyclopropylamine derivatives and their medical use
US8859555B2 (en) 2009-09-25 2014-10-14 Oryzon Genomics S.A. Lysine Specific Demethylase-1 inhibitors and their use
US8946296B2 (en) 2009-10-09 2015-02-03 Oryzon Genomics S.A. Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
US8962627B2 (en) 2009-10-30 2015-02-24 Prestwick Chemical, Inc. Oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
CN102060855B (zh) * 2009-11-12 2014-04-16 上海药明康德新药开发有限公司 一种八氢-吡喏-并[3,4-c]吡啶-衍生物的制备方法
US9186337B2 (en) 2010-02-24 2015-11-17 Oryzon Genomics S.A. Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae
WO2011106105A2 (en) 2010-02-24 2011-09-01 Oryzon Genomics, S.A. Inhibitors for antiviral use
RU2599248C2 (ru) 2010-04-19 2016-10-10 Оризон Дженомикс С.А. Лизинспецифические ингибиторы деметилазы-1 и их применение
US9006449B2 (en) 2010-07-29 2015-04-14 Oryzon Genomics, S.A. Cyclopropylamine derivatives useful as LSD1 inhibitors
ME03085B (me) 2010-07-29 2019-01-20 Oryzon Genomics Sa Demetilaza inhibitori lsd1 zasnovani na arilciklopropilaminu i njihova medicinska primjena
US9061966B2 (en) 2010-10-08 2015-06-23 Oryzon Genomics S.A. Cyclopropylamine inhibitors of oxidases
WO2012072713A2 (en) 2010-11-30 2012-06-07 Oryzon Genomics, S.A. Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
EP3981395A1 (en) 2011-02-08 2022-04-13 Oryzon Genomics, S.A. Lysine demethylase inhibitors for myeloproliferative disorders
BR112014009238B1 (pt) 2011-10-20 2022-08-09 Oryzon Genomics S.A. Compostos de (hetero)aril ciclopropilamina, seus usos e composições farmacêuticas
BR112014009306B1 (pt) 2011-10-20 2021-07-20 Oryzon Genomics S.A. Compostos de (hetero)aril ciclopropilamina como inibidores de lsd1
EP2781519B1 (en) * 2011-11-15 2019-10-30 ST Pharm Co., Ltd. Novel antiviral pyrrolopyridine derivative and a production method for same
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為ＮＩＫ抑制劑的新穎３－（１Ｈ－吡唑－４－基）－１Ｈ－吡咯并［２，３－ｃ］吡啶衍生物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作ＮＩＫ抑制劑之新的1-(４-嘧啶基)-１Ｈ-吡唑並[３,２-ｃ]吡啶衍生物
GB201321735D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
ME03654B (me) * 2014-02-13 2020-07-20 Incyte Corp Ciklopropilamini kao lsd1 inhibitori
PT3105226T (pt) * 2014-02-13 2019-11-06 Incyte Corp Ciclopropilaminas como inibidores de lsd1
JP6616412B2 (ja) 2014-10-23 2019-12-04 ヤンセン ファーマシューティカ エヌ．ベー． Ｎｉｋ阻害剤としての新規のピラゾロピリミジン誘導体
AU2015334914B2 (en) 2014-10-23 2019-09-19 Janssen Pharmaceutica Nv New thienopyrimidine derivatives as NIK inhibitors
MX371153B (es) * 2014-10-23 2020-01-20 Janssen Pharmaceutica Nv Nuevos compuestos como inhibidores de la cinasa inductora de nf-kb (nik).
US9981962B2 (en) 2014-10-23 2018-05-29 Janssen Pharmaceutica Nv Pyrazole derivatives as NIK inhibitors
EP3241830A1 (de) 2016-05-04 2017-11-08 Bayer CropScience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
US11352322B2 (en) * 2016-05-09 2022-06-07 Jubilant Epicore LLC Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors
KR102435080B1 (ko) 2016-07-19 2022-08-22 바이엘 크롭사이언스 악티엔게젤샤프트 해충 방제제로서의 축합 바이시클릭 헤테로사이클 유도체
MX2019001918A (es) 2016-08-15 2019-09-06 Bayer Cropscience Ag Derivados del heterociclo biciclico condensado como agentes de control de plagas.
KR102148294B1 (ko) * 2017-03-24 2020-08-26 에스티팜 주식회사 신규한 피롤로피리딘 유도체, 이의 제조방법 및 용도
KR20220023187A (ko) * 2020-08-20 2022-03-02 에스티팜 주식회사 피롤로피리딘 유도체 및 이들의 용도
CA3262084A1 (en) * 2022-08-05 2024-02-08 The Governing Council Of The University Of Toronto HISTONE DEACETYLASE INHIBITORS AND THEIR USE

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194747A (en) * 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
GB8720125D0 (en) 1987-08-26 1987-09-30 Roussel Lab Ltd Chemical compounds
US5616609A (en) 1991-08-08 1997-04-01 Ikekawa; Tetsuro Carcinostatic compound and production thereof
GB2271566A (en) 1992-10-14 1994-04-20 Merck & Co Inc HIV integrase inhibitors
US5726203A (en) 1993-07-19 1998-03-10 Li; Zelin Qinghaosu derivatives against AIDS
GB2306476A (en) 1995-10-27 1997-05-07 Merck & Co Inc Hiv integrase inhibitors
US6057297A (en) * 1996-08-06 2000-05-02 Polifarma S.P.A. Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
AU4917397A (en) 1996-10-31 1998-05-22 Merck & Co., Inc. Benzodiazepine hydrazide derivatives as inhibitors of hiv integrase
GB2327674A (en) 1997-07-29 1999-02-03 Merck & Co Inc HIV integrase inhibitors
US6403347B1 (en) * 1998-02-03 2002-06-11 Merck & Co., Inc. HIV integrase inhibitors
ES2188184T3 (es) 1998-06-12 2003-06-16 Sod Conseils Rech Applic Compuestos de beta-carbolinas.
CA2372791A1 (en) 1999-05-12 2000-11-16 Nouri Neamati Thiazepine and oxazepine inhibitors of hiv-1 integrase
US6245806B1 (en) 1999-08-03 2001-06-12 Merck & Co., Inc. HIV integrase inhibitors
WO2001027309A1 (en) * 1999-10-13 2001-04-19 Merck & Co., Inc. Hiv integrase inhibitors
EP1209158A1 (en) 2000-11-18 2002-05-29 Aventis Pharma Deutschland GmbH Substituted beta-carbolines
AU2001269895B2 (en) * 2000-06-16 2005-10-20 Bristol-Myers Squibb Company Hiv integrase inhibitors
WO2002002516A2 (en) 2000-06-30 2002-01-10 Thomas Jefferson University Inhibitors of hiv integrase
MXPA03007765A (es) * 2001-03-01 2003-12-08 Shionogi & Co Compuestos heteroarilo que contienen nitrogeno, que tienen actividad inhibitoria contra virus de inmunodeficiencia humana integrasa.
WO2002070491A1 (en) 2001-03-01 2002-09-12 Shionogi & Co., Ltd. Nitrogenous heteroaromatic ring derivative having hiv integrase inhibitory activity
JP2003171381A (ja) 2001-09-25 2003-06-20 Takeda Chem Ind Ltd エントリー阻害剤
JP2003119137A (ja) 2001-10-10 2003-04-23 Japan Tobacco Inc Ｈｉｖ阻害剤
DE60216952T2 (de) 2001-10-19 2007-07-05 Transtech Pharma Inc. Beta-carbolin-derivate als ptp-inhibitoren
DE60218511T2 (de) * 2001-10-26 2007-10-25 Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.P.A. Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase
JP4497347B2 (ja) 2001-12-05 2010-07-07 塩野義製薬株式会社 Ｈｉｖインテグラーゼ阻害活性を有する誘導体
CA2469592C (en) 2001-12-12 2005-08-23 Bristol-Myers Squibb Company Hiv integrase inhibitors
DE60315796T2 (de) 2002-01-17 2008-06-05 Merck & Co., Inc. Hydroxynaphthyridinoncarbonsäureamide, die sich als inhibitoren der hiv-integrase eignen
AU2003220170B2 (en) * 2002-03-15 2008-12-11 Merck Sharp & Dohme Corp. N-(Substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as HIV integrase inhibitors
WO2003082881A2 (en) 2002-03-28 2003-10-09 Procyon Biopharma Inc. Pyridoxal-5-phosphate derivatives as hiv integrase inhibitors
US20050165000A1 (en) 2002-04-10 2005-07-28 Robertson Sandra K. Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant
AU2002335027A1 (en) 2002-10-15 2004-05-04 Chiron Corporation Treatment of tnf-alpha-mediated disorders with casein kinase i epsilon inhibitors
PA8586801A1 (es) 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
CA2513141A1 (en) 2003-01-27 2004-08-12 Pfizer Inc. Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
WO2005103003A2 (en) 2004-04-26 2005-11-03 Pfizer Inc. Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
BRPI0510306A (pt) 2004-04-26 2007-09-04 Pfizer inibidores da enzima de hiv integrase,composição farmacêutica contendo os referidos inibidores bem como seu uso
CA2578841A1 (en) 2004-09-07 2006-03-16 Pfizer Inc. Inhibitors of the hiv integrase enzyme

Also Published As

Publication number Publication date
MXPA06012449A (es) 2007-01-17
US7468375B2 (en) 2008-12-23
WO2005103003A2 (en) 2005-11-03
US20050277662A1 (en) 2005-12-15
JP2007534739A (ja) 2007-11-29
WO2005103003A3 (en) 2006-03-16
EP1756103A2 (en) 2007-02-28
CA2564356A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
BRPI0510319A (pt) inibidores da enzima integrase de hiv
BRPI0418102A (pt) derivados de quinolina
BR0308081A (pt) Inibidores de histona desacetilase
BRPI0515174A (pt) composto ou sais do mesmo, composição farmacêutica, e, uso de um produto farmacêutico
EA200600480A1 (ru) Имидазопиридинзамещённые тропановые производные, обладающие активностью антагониста ccr5 рецептора, для лечения вируса иммунодефицита человека (вич) и воспаления
BRPI0108395B8 (pt) derivados de pirrolopirimidinona, processos de preparação e uso
UA100005C2 (ru) Ингибиторы репликации вируса иммунодефицита человека
CY1116103T1 (el) Υποκατεστημενα παραγωγα 1,2,3,4-τετραϋδροϊσοκινολινης
MA31889B1 (fr) N-phenyl -bipyrrolidine-urees substituees et utilisation therapeutique de celles-ci
DK1712547T3 (da) Bicycloesterderivat
BRPI0507675A (pt) derivados de 2'-c-metil nucleosìdeo
BRPI0410418A (pt) fenil quinolinas e seu uso como moduladores do receptor de estrogênio
BRPI0513901A (pt) derivados de uréia cìclicos substituìdos, preparação dos mesmos e uso farmacêutico dos mesmos como inibidores de cinase
BRPI0408767A (pt) inibidores de transcriptase reversa não-nucleosìdeos i para o tratamento de doenças mediadas pelo hiv
BRPI0818626A2 (pt) n-fenil-bipirrolidina carboxamidas substituída e uso terapêutico da mesma
SE0401342D0 (sv) Therapeutic compounds
BRPI0413094A (pt) derivados de quinolina e seu uso em terapia
BRPI0414948A (pt) derivados de pirazolo-e-imidazo pirimidina
EA200702242A1 (ru) Использование сульфонамидного соединения для улучшения фармакокинетики лекарственного средства
BRPI0506477A (pt) compostos farmaceuticamente úteis e inovadores
BR0314860A (pt) Derivados de pirazol
BR0113581A (pt) Derivados de aril-piperazinas e seu uso como psicofármacos
BRPI0514724A (pt) inibidores da enzima hiv integrase
MX2024009773A (es) Composicion farmaceutica que comprende derivados de difenildiazol y metodos de uso.
BRPI0510306A (pt) inibidores da enzima de hiv integrase,composição farmacêutica contendo os referidos inibidores bem como seu uso

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.